Literature DB >> 12406325

Arsenic induces tumor necrosis factor alpha release and tumor necrosis factor receptor 1 signaling in T helper cell apoptosis.

Hsin-Su Yu1, Wei-Ting Liao, Kee-Lung Chang, Chia-Li Yu, Gwo-Shing Chen.   

Abstract

Long-term exposure to arsenic induces arsenical cancers in human beings. Arsenic has been shown to induce apoptosis in a variety of cell systems. Previous studies revealed that patients with arsenic-induced Bowen's disease showed a defective cell-mediated immunity and decreased percentages of T cell and T helper cell subpopulations in peripheral mononuclear cells. The purpose of this study was to investigate the effects of arsenic on T cell survival and function in mononuclear cells. Arsenic concentrations higher than 1 micro M induced tumor necrosis factor alpha release from mononuclear cells and caused a cytotoxic effect on T cells. When exposed to higher concentrations of arsenic, apoptosis was induced. CD4+ cells were the major apoptoic population in mononuclear cells. Tumor necrosis factor receptor 1 expression on CD4+ cells, but not Fas/FasL, was significantly enhanced by arsenic treatment compared to other mononuclear cells. Increased expressions of tumor necrosis factor receptor 1 related death domain proteins and activated caspases were observed. These findings indicate that tumor necrosis factor receptor 1 signaling is the major pathway in arsenic-induced T helper cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406325     DOI: 10.1046/j.1523-1747.2002.00475.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

Review 1.  Old dog, new trick: Trivalent arsenic as an immunomodulatory drug.

Authors:  Yishan Ye; Béatrice Gaugler; Mohamad Mohty; Florent Malard
Journal:  Br J Pharmacol       Date:  2020-03-12       Impact factor: 8.739

Review 2.  Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence.

Authors:  Ana Navas-Acien; Ellen K Silbergeld; Robin A Streeter; Jeanne M Clark; Thomas A Burke; Eliseo Guallar
Journal:  Environ Health Perspect       Date:  2006-05       Impact factor: 9.031

3.  Unexplained dyspnea in a patient of chronic arsenicosis: A diagnostic challenge and learning curve for physicians.

Authors:  Amitabha Sengupta; Arnab Maji; Debraj Jash; Malay Maikap
Journal:  Lung India       Date:  2015 Mar-Apr

4.  Subchronic arsenism-induced oxidative stress and inflammation contribute to apoptosis through mitochondrial and death receptor dependent pathways in chicken immune organs.

Authors:  Hongjing Zhao; Ying He; Siwen Li; Xiao Sun; Yu Wang; Yizhi Shao; Zhijun Hou; Mingwei Xing
Journal:  Oncotarget       Date:  2017-06-20

5.  Arsenic exposure during pregnancy and postpartum maternal glucose tolerance: evidence from Bangladesh.

Authors:  Abby F Fleisch; Sudipta Kumer Mukherjee; Subrata K Biswas; John F Obrycki; Sheikh Muhammad Ekramullah; D M Arman; Joynul Islam; David C Christiani; Maitreyi Mazumdar
Journal:  Environ Health       Date:  2022-01-14       Impact factor: 5.984

6.  Reduction in urinary arsenic levels in response to arsenic mitigation efforts in Araihazar, Bangladesh.

Authors:  Yu Chen; Alexander van Geen; Joseph H Graziano; Alexander Pfaff; Malgosia Madajewicz; Faruque Parvez; A Z M Iftekhar Hussain; Vesna Slavkovich; Tariqul Islam; Habibul Ahsan
Journal:  Environ Health Perspect       Date:  2007-02-05       Impact factor: 9.031

7.  Development of an Antioxidant Phytoextract of Lantana grisebachii with Lymphoprotective Activity against In Vitro Arsenic Toxicity.

Authors:  Elio A Soria; Patricia L Quiroga; Claudia Albrecht; Sabina I Ramos Elizagaray; Juan J Cantero; Guillermina A Bongiovanni
Journal:  Adv Pharmacol Sci       Date:  2014-06-05

8.  Cytokinesis-Block Micronucleus Assay Using Human Lymphocytes as a Sensitive Tool for Cytotoxicity/Genotoxicity Evaluation of AgNPs.

Authors:  Balam Ruiz-Ruiz; María Evarista Arellano-García; Patricia Radilla-Chávez; David Sergio Salas-Vargas; Yanis Toledano-Magaña; Francisco Casillas-Figueroa; Roberto Luna Vazquez-Gomez; Alexey Pestryakov; Juan Carlos García-Ramos; Nina Bogdanchikova
Journal:  ACS Omega       Date:  2020-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.